Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result

Dutch startup VivArt-X raises €660K to improve women’s health post breast-conserving surgery

Vishal Singh by Vishal Singh
November 20, 2023
in (Crowd)funding, News
VivArt-X

Image credit: VivArt-X

LinkedInTwitterWhatsAppFacebook
Read this article in:

Eindhoven-based VivArt-X, a startup that aims to improve women’s lives after breast-conserving surgery, has secured €660K in a pre-seed round of funding to advance the development of its biodegradable biomaterial for regenerating human tissue.

The proof-of-concept focuses on improving the survival rate of transplanted fat cells in breast cancer patients, particularly those who undergo lumpectomy and subsequently require breast reconstruction surgery.

“This funding enables us to advance our lead programme into pre-clinical development, a significant step in our mission to improve regenerative application,” says VivArt-X.

Investors supporting VivArt-X

The investment came from Brabant Startup Fonds, the Brabant Development Agency (BOM), TU/e Participations, and various informal investors.

BOM investment manager Paul Vernooij says, “VivArt-X is addressing a very important medical need – upgrading reconstructive surgery for people who have suffered breast cancer.”

“The company’s smart biomaterials improve the effectiveness of fat transplantations, resulting in a better recovery rate and reducing the need for further breast surgery.”

“The investment helps VivArt X to achieve this major objective and also bolsters the Brabant ecosystem in the field of biomaterials.”

The BOM helps entrepreneurs in securing support and funding for critical technologies, healthy futures, climate-neutral energy, and sustainable food sources. 

Serving as the executive branch for the Province of Brabant and the Ministry of Economic Affairs and Climate Policy, BOM also facilitates the growth of startups into scale-ups and businesses with global ambitions.

1 in 7 women at risk of developing breast cancer in their lifetime

VivArt-X highlights a concerning statistic, stating that out of 2.3 million global breast cancer sufferers, around half undergo the removal of cancerous tissue, leading to a subsequent need for breast reconstruction surgery.

VivArt-X aims to improve the often unsatisfactory outcomes of current procedures through innovative solutions.

According to the company, postoperative breast cancer patients often endure significant physical and emotional pain, with the choice of reconstruction strategy and recovery time playing a crucial role.

Recognising an unmet need, VivArt-X aims to address this challenge by introducing a synthetic, degradable biomaterial.

This innovation aims to enable surgeons to predictably restore and regenerate breast tissue, ultimately improving the quality of life for breast cancer patients through personalised and effective breast reconstruction.

The company was founded in 2022 by Dr. Ir. Dan Jing Wu and Professor Dr. Patricia Dankers.

Other applications

VivArt-X’s medical device aims for the healthy restoration of breast tissue with broader applications beyond breast regeneration.

VivArt-X CEO and founder Dan Jing Wu says, “We are extremely grateful for the support of our investors and partners and their confidence in us. This valuable backing allows our team to accelerate R&D and make a significant contribution to tackling crucial issues concerning women’s health.”

Tags: Dutch Startupsfundingnews
ShareTweetSendShare

Partner content | Partner with us

Dutch-Swiss startup Cradle raises €21.9M for pioneering Generative AI in protein design

Accelerate your startup: Philips Innovation Award 2024 for student innovators and recent graduates!

Breaking Barriers: How PE Front Office drives success for Investment Management and Investor Relations Teams in Private Equity and Private Debt

These are the top tools to supercharge your e-commerce business in Europe in 2024

Amsterdam’s ImpactPilot set to revolutionise customer success through HubSpot integration

Silicon Canals | Find a job

Top news | from Amsterdam

Amsterdam’s LAYCO raises €300K to make healthcare more sustainable and accessible

Meet the winners of the Amsterdam Science & Innovation Award 2023

Amsterdam’s grocery app Crisp bags €35M from Adriaan Mol, Thomas Plantenga, others 

Amsterdam fintech Silverflow raises €15M to fuel its “aggressive” global expansion plans

Amsterdam’s Joanna Invests unveils €5M package deal to invest €5M in female founders

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Find a job
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X